Glucocorticoid toxicity reduction with Mepolizumab using the glucocorticoid toxicity index.
Liam G HeaneyJohn H StoneYuqing ZhangKirsty HoneyfordLouise DunnR Jayne LoganLorcan P A McGarveyClaire A ButlerLiam G HeaneyPublished in: The European respiratory journal (2021)
Mepolizumab resulted in substantial oral glucocorticoid reduction but this did not correlate with reduction in oral glucocorticoid toxicity, which varies widely at the individual patient level. Oral glucocorticoid reduction is not a comprehensive measure of response to mepolizumab.
Keyphrases